ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

ANNX Annexon Inc

5.85
-0.16 (-2.66%)
Jun 14 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Annexon Inc ANNX NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.16 -2.66% 5.85 19:00:00
Open Price Low Price High Price Close Price Previous Close
5.89 5.61 5.98 5.62 6.01
more quote information »

Recent News

Date Time Source Heading
6/12/202411:28EDGAR2Form 8-K - Current report
6/07/202420:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
6/07/202420:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
6/07/202420:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
6/07/202420:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
6/07/202415:42EDGAR2Form 8-K - Current report
6/06/202420:57EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
6/05/202415:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
6/04/202416:21EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
6/04/202406:05EDGAR2Form 8-K - Current report
5/13/202415:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
5/13/202415:05EDGAR2Form 8-K - Current report
4/16/202408:00GLOBETurnstone Biologics Appoints William Waddill to its Board of..
2/21/202415:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/21/202415:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/21/202415:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/20/202414:15EDGAR2Form 144 - Report of proposed sale of securities
2/20/202414:12EDGAR2Form 144 - Report of proposed sale of securities
2/14/202419:46EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/14/202418:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/14/202418:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/14/202418:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/14/202414:45EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/13/202418:23EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/13/202417:57EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/12/202415:24EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2/12/202414:45EDGAR2Form 144 - Report of proposed sale of securities
2/12/202414:41EDGAR2Form 144 - Report of proposed sale of securities
2/12/202414:39EDGAR2Form 144 - Report of proposed sale of securities
1/23/202416:00EDGAR2Form 4/A - Statement of changes in beneficial ownership of..
1/23/202415:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/08/202415:09EDGAR2Form 8-K - Current report
1/07/202419:00GLOBEAnnexon Outlines 2024 Priorities with Late-Stage Clinical..
12/29/202315:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/27/202315:50EDGAR2Form 144 - Report of proposed sale of securities
12/27/202305:30GLOBEAnnexon Biosciences to Present at the 42nd Annual J.P...
12/22/202316:28EDGAR2Form 8-K/A - Current report: [Amend]
12/21/202315:09EDGAR2Form 8-K - Current report
12/21/202315:05EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
12/20/202316:27GLOBEAnnexon Announces Pricing of $125.0 Million Underwritten..
12/20/202316:24EDGAR2Form FWP - Filing under Securities Act Rules 163/433 of free..
12/20/202316:17EDGAR2Form 8-K - Current report
12/20/202316:10GLOBEAnnexon Outlines Global Registrational Program for ANX007 in..
12/20/202316:08GLOBEAnnexon Reports Phase 1 Results for ANX1502, its Oral Small..
12/18/202315:01GLOBEAnnexon Reports Inducement Grants to New Employees Under..
11/22/202315:01GLOBEAnnexon Biosciences to Participate in the 6th Annual..
11/13/202315:10EDGAR2Form 8-K - Current report
11/13/202305:30GLOBEAnnexon Reports Significant Progress with its Priority..
11/09/202305:30GLOBEAnnexon Biosciences to Participate in 2023 Jefferies London..
10/24/202315:30EDGAR2Form 8-K - Current report

Your Recent History

Delayed Upgrade Clock